$1.01
-0.09-8.18%
In chiusura: Nov 17, 4:00 PM EST
$1.08
0.076.93%
Post-mercato: 9:29 AM EST

Tvardi Therapeutics (TVRD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 13, 2026 | $-0.48 | $-0.56 | 14.3 % |
| Q2 | Aug 14, 2026 | $-0.69 | $-0.64 | -7.81 % |
| Q1 | May 8, 2026 | $-0.73 | $-0.70 | -4.29 % |
| Q4 | Mar 31, 2026 | $-0.78 | $-0.56 | -39.3 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.64 | $-0.70 | $-0.56 |
| Actual | $-0.48 | $-0.69 | $-0.73 | $-0.78 |
| Surprise | +14.3% | -7.81% | -4.29% | -39.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.48 | $-0.36 | $-0.50 | $-0.56 |
| Revenue | ||||
| Consensus | — | — | — | — |